ESTRO Multidisciplinary Management of Breast Cancer 2017

248 / 1816

Early stage, low risk (DCIS; T1G1-2; T2G1) :
 LC >>> DM: SX/RT
Early stage, high risk (T1G3; T2G2-3; N1a):
 LC: SX/RT effect  by .
 DM: Syst.Th.importance LC : need for SX/RT
Late stage (T3-4; N2a-3):
 DM >>> LC: .  importance of LC: SX/RT
Poortmans P. Lancet. 2014 Jun 21;383(9935):2104-6.
Less local treatment: interaction loc-syst T